Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-08-25

FDA Approved: SKYTROFA — Original Application (Ascendis Pharma Endocrinology, Inc.)

View source ↗

Summary

FDA approves SKYTROFA (lonapegsomatropin-tcgD) from Ascendis Pharma Endocrinology as an original application. It provides a once-weekly growth hormone therapy f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Skytrofa (lonapegsomatropin)

Snippet

ORIG AP for SKYTROFA (LONAPEGSOMATROPIN-TCGD)